Cellular and subcellular localization of Huntington aggregates in the brain of a rat transgenic for Huntington disease

Abstract

Huntington disease (HD) is a progressive neurodegenerative disorder characterized by emotional, cognitive, and motor dysfunctions. Aggregation of huntingtin is a hallmark of HD and, therefore, a crucial parameter for the evaluation of HD animal models. We investigated here the regional, cellular, and subcellular distribution of N-terminal huntingtin aggregates and associated neuropathological changes in the forebrain of a rat transgenic for HD (tgHD). The tgHD rat brain showed enormously enlarged lateral ventricles and a similar atrophy of cortical and subcortical areas as known in HD patients. Huntingtin aggregates of varying size and forms were regionally identified in neuronal nuclei, cytoplasm, dendrites, dendritic spines, axons, and synaptic terminals, closely resembling the results described earlier for human HD brains and in established HD mouse models. Huntingtin aggregates in mitochondria support mitochondrial dysfunction as contributing to the disease pathogenesis. Dark cell degeneration was reminiscent of results in HD individuals and HD mouse models. Interestingly, huntingtin aggregates were especially well accumulated in two interacting limbic forebrain systems, the ventral striatopallidum and the extended amygdala, which may contribute to the early onset of emotional changes observed in the tgHD rat. In conclusion, the tgHD rat model reflects to a remarkable extent the cellular and subcellular neuropathological key features as observed in human HD and HD mouse brains and hints of changes in limbic forebrain systems, which may elucidate the emotional dysfunction in the tgHD rat and affective disturbances in HD patients.

Neuronal Apoptosis and Autophagy Cross Talk in Aging PS/APP Mice, a Model of Alzheimer's Disease

“…Dark degenerating neurons, or dark neurons, have been detected in various pathological conditions including ischemia, epilepsy, 73 and chronic neurodegenerative states, such as Huntington's disease and models of this disease. 74,82,83 Our data provide clear evidence that caspase-3 is minimally activated in neurons undergoing dark cell degeneration; however, it remains to be investigated whether or not dark cell degeneration leads to neuron loss and whether it represents a distinct type of neuronal cell death, a stage of apoptosis preceding the activation of caspase-3, or a form of apoptosis involving a different set of caspases. The existence of at least two modes of neurodegeneration in the same mouse model underscores the complexity of cell death patterns in chronic neurodegenerative disease.…”

Theta-Burst Transcranial Magnetic Stimulation Alters Cortical Inhibition

“…Electron microscopic sections were analyzed to compare the cellular integrity of PV neurons showing either low or high expression of the PV protein and to detect neuronal damage. A detailed description of the method has been published previously (Petrasch-Parwez et al, 2004, 2007. Sections for immunohistochemistry were reduced in 1% NaBH 4 in PBS for 30 min and incubated freely floating for 30 min in PBS containing 10% normal NGS.…”

Neurodegeneration and Motor Dysfunction in a Conditional Model of Parkinson's Disease

“…and transcardially perfused by a 4% PFA. Fixed brains were removed from the skull, coronally cut into 50 m vibratome sections, and immunostained as recently described (Petrasch-Parwez et al, 2007). Briefly, after reduction and blocking, sections were incubated for 72 h at 4°C with anticalbindin D-28k (1:2000) (CB-38a; Swant, Bellinzona, Switzerland), anti-tyrosine hydroxylase (TH) (1:1000) (AB 152; Chemicon, Hofheim, Germany), or 15G7-␣-syn (1:10) (Kahle et al, 2000) in 10% normal goat serum or 10% NRS.…”